Researchers Reverse Kidney Damage in Mice by Targeting Ceramide-Induced Mitochondrial Damage
By
ashishgupta2209
A respectable bake. You'd come back tomorrow for another.
Summary
Researchers at University of Utah Health discovered that fatty molecules called ceramides trigger acute kidney injury (AKI) by damaging mitochondria in kidney cells. The team found that by altering ceramide metabolism or using a drug candidate, they could protect mitochondrial function and completely prevent kidney injury in mice. This breakthrough offers potential for developing treatments for AKI, a life-threatening condition affecting over half of intensive care patients with no currently approved medications.
Key quotes
· 5 pulledSerious injury to short-term kidney function, known as acute kidney injury (AKI), can be life-threatening and also raise the likelihood of developing permanent chronic kidney disease.
Researchers at University of Utah Health (U of U Health) have discovered that fatty molecules called ceramides initiate AKI by damaging the mitochondria that supply energy to kidney cells.
By altering ceramide metabolism or using a new drug candidate, the team was able to protect mitochondrial function and completely prevent kidney injury in mice.
AKI can occur after major stressors such as sepsis or heart surgery, and more than half of all intensive care patients experience it.
No approved medications currently exist to treat this condition.
You might also wanna read
Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds
Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a
Spinach-derived photosynthetic treatment shows promise for dry eye disease
Scientists at the National University of Singapore have developed an experimental treatment for dry eye disease that uses photosynthetic mac
Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1
Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
